Switzerland · Series F startup
8 rounds we have observed, with the 14 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$321Mraised across 8 rounds since 2009, from 8 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
No investor was named in the report.
From a historical funding record
Wellcome TrustReported by finsmes.com
Declaration Partners
Debiopharm Group
KorysFrom a historical funding record
Reported by finsmes.com
Advent Venture Partners
AescapDebiopharm Group
KBC Private EquityReported by biocartis.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Debiopharm GroupPMV Tina FundAdvent Venture PartnersWellcome TrustAescapDeclaration Partners
Blisce/KBC Private EquityMissing a round, or an investor who was in one? Tell us.
This firm lists Biocartis as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Biocartis's investors include Johnson & Johnson Development Corporation (JJDC), Debiopharm Group, PMV Tina Fund, Advent Venture Partners and Wellcome Trust, and 9 more on record.
Biocartis has raised $321M across 8 rounds since 2009. One round did not disclose an amount, so the total is a floor.
Biocartis's most recent round was a Series F of $85M in Sept 2014.
Biocartis's largest round on record is $96M (Series C), in Nov 2011.
Biocartis's first round on record, in Oct 2009, was backed by Advent Venture Partners and Aescap.
Biocartis's latest named round is a Series F, in Sept 2014.
Biocartis is based in Switzerland.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Switzerland · 